NEW YORK (GenomeWeb News) - BG Medicine today said it has filed for an initial public offering of its shares on the Euronext Amsterdam Exchange.
 
The biomarker and diagnostics developer said it has filed a registration statement with the US Securities and Exchange Commission but has not yet determined the number of shares it plans to issue and it has not set an opening price for its common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.